Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Operating Expenses: 2018-2019

Historic Operating Expenses for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $2.8 million.

  • DiaMedica Therapeutics' Operating Expenses rose 30.85% to $2.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $11.6 million, marking a year-over-year increase of 59.68%. This contributed to the annual value of $26.7 million for FY2024, which is 25.46% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Operating Expenses of $2.8 million as of Q4 2019, which was up 4.10% from $2.7 million recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Operating Expenses registered a high of $3.4 million during Q1 2019, and its lowest value of $1.3 million during Q1 2018.
  • For the 2-year period, DiaMedica Therapeutics' Operating Expenses averaged around $2.4 million, with its median value being $2.4 million (2018).
  • Data for DiaMedica Therapeutics' Operating Expenses shows a peak YoY soared of 161.94% (in 2019) over the last 5 years.
  • DiaMedica Therapeutics' Operating Expenses (Quarterly) stood at $2.1 million in 2018, then skyrocketed by 30.85% to $2.8 million in 2019.
  • Its Operating Expenses stands at $2.8 million for Q4 2019, versus $2.7 million for Q3 2019 and $2.7 million for Q2 2019.